Literature DB >> 18166149

Resveratrol attenuates the expression of HMG-CoA reductase mRNA in hamsters.

Il Jin Cho1, Ji Yun Ahn, Suna Kim, Myung Sook Choi, Tae Youl Ha.   

Abstract

We investigated the hypolipidemic effect of resveratrol focused on the mRNA expression and hepatic HMG-CoA reductase (HMGR) activity in hamsters fed a high-fat diet. Male Syrian Golden hamsters were fed a high-fat diet containing 0.025% fenofibrate or 0.025% resveratrol for 8 weeks. The concentrations of serum total cholesterol and triglyceride were significantly lower in the resveratrol-fed group than in the control group. The resveratrol contained diet significantly decreased Apo B, Lp(a), and cholesterol-ester-transport protein (CETP) concentrations, but increased Apo A-I levels and the Apo A-I/Apo B ratio. The contents of cholesterol and triglyceride in hepatic tissue were significantly lower in the resveratrol group than in the control group. Real-time PCR analysis revealed that HMGR mRNA expression was significantly lower in the resveratrol group than in the control group. These results indicate that dietary resveratrol reduces serum cholesterol by down-regulating hepatic HMGR mRNA expression in hamsters fed a high-fat diet.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18166149     DOI: 10.1016/j.bbrc.2007.12.140

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  39 in total

Review 1.  Diabetic complications in pregnancy: is resveratrol a solution?

Authors:  Chandra K Singh; Ambrish Kumar; Holly A Lavoie; Donald J Dipette; Ugra S Singh
Journal:  Exp Biol Med (Maywood)       Date:  2013-05-29

2.  Resveratrol and pterostilbene attenuated smokeless tobacco induced cardiovascular aberrations in estrogen deficient female rats.

Authors:  A Nirwane; A Majumdar
Journal:  Toxicol Res (Camb)       Date:  2016-08-03       Impact factor: 3.524

Review 3.  Herbal medicines and nonalcoholic fatty liver disease.

Authors:  Hong Yao; Yu-Jie Qiao; Ya-Li Zhao; Xu-Feng Tao; Li-Na Xu; Lian-Hong Yin; Yan Qi; Jin-Yong Peng
Journal:  World J Gastroenterol       Date:  2016-08-14       Impact factor: 5.742

Review 4.  Resveratrol in cardiovascular disease: what is known from current research?

Authors:  Hong Wang; Yue-Jin Yang; Hai-Yan Qian; Qian Zhang; Hui Xu; Jian-Jun Li
Journal:  Heart Fail Rev       Date:  2012-05       Impact factor: 4.214

Review 5.  Effects of resveratrol in experimental and clinical non-alcoholic fatty liver disease.

Authors:  Sara Heebøll; Karen Louise Thomsen; Steen B Pedersen; Hendrik Vilstrup; Jacob George; Henning Grønbæk
Journal:  World J Hepatol       Date:  2014-04-27

6.  Resveratrol potentiates effect of simvastatin on inhibition of mevalonate pathway in human endometrial stromal cells.

Authors:  Jesus A Villanueva; Anna Sokalska; Amanda B Cress; Israel Ortega; Kaylon L Bruner-Tran; Kevin G Osteen; Antoni J Duleba
Journal:  J Clin Endocrinol Metab       Date:  2013-02-05       Impact factor: 5.958

Review 7.  New compounds able to control hepatic cholesterol metabolism: Is it possible to avoid statin treatment in aged people?

Authors:  Laura Trapani; Marco Segatto; Valentina Pallottini
Journal:  World J Hepatol       Date:  2013-12-27

8.  Antiobesity and vasoprotective effects of resveratrol in apoE-deficient mice.

Authors:  Seon-Min Jeon; Seung-A Lee; Myung-Sook Choi
Journal:  J Med Food       Date:  2014-01-16       Impact factor: 2.786

9.  Resveratrol, wine, and atherosclerosis.

Authors:  Kailash Prasad
Journal:  Int J Angiol       Date:  2012-03

10.  Inulin-enriched pasta affects lipid profile and Lp(a) concentrations in Italian young healthy male volunteers.

Authors:  Francesco Russo; Guglielmina Chimienti; Giuseppe Riezzo; Gabriella Pepe; Giuseppe Petrosillo; Marisa Chiloiro; Emanuele Marconi
Journal:  Eur J Nutr       Date:  2008-10-13       Impact factor: 5.614

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.